Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India · Delayed Price · Currency is INR 750.00
-19.85 (-2.58%)
Nov 12, 2026, 3:30 PM IST
NSE:AKUMS Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 48,289 | 43,614 | 41,209 | 41,817 | 36,572 | 36,752 |
Revenue Growth | 17.48% | 5.83% | -1.45% | 14.34% | -0.49% | 34.81% |
Gross Profit Gross Profit Growth | 20,015 | 17,717 | 16,216 | 15,613 | 13,079 | 12,607 |
Operating Income Operating Income Growth | 5,065 | 3,701 | 3,101 | 3,590 | 1,895 | 3,158 |
Net Income Net Income Growth | 3,638 | 2,552 | 3,382 | -40.35 | 948.55 | -2,525 |
Earnings Per Share EPS Growth | 23.76 | 16.67 | 22.60 | -0.28 | 6.63 | -17.65 |
EPS Growth | 14.72% | -26.26% | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
CDMO CDMO Growth | 41,754 | 37,102 | 34,402 | 36,196 | 31,206 | 29,776 |
API API Growth | 2,081 | 2,314 | 2,771 | 2,784 | 2,223 | 1,361 |
Domestic Branded Formulations Domestic Branded Formulations Growth | 4,641 | 4,463 | 4,336 | 3,985 | - | - |
International Branded Formulations International Branded Formulations Growth | 1,643 | 1,435 | 1,426 | 1,248 | - | - |
Trade Generics Trade Generics Growth | 962.66 | 1,003 | 1,179 | 1,767 | - | - |
Inter-Segment Inter-Segment Growth | -2,817 | -2,727 | -2,933 | -4,198 | -4,430 | -3,447 |
Total Total Growth | 48,265 | 43,590 | 41,182 | 41,782 | 36,548 | 36,719 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 16,800 | 16,806 | 5,683 | 2,771 | 1,500 | 1,028 |
Total Debt Total Debt Growth | 1,171 | 1,917 | 1,476 | 5,652 | 6,229 | 3,998 |
Net Cash (Debt) Net Cash Growth | 15,629 | 14,889 | 4,208 | -2,882 | -4,729 | -2,969 |
Net Cash Growth | -0.08% | 253.85% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 102.07 | 97.25 | 28.12 | -20.14 | -33.05 | -20.76 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,847 | 11,812 | 4,652 | 4,983 | 1,766 | 318.54 |
Capital Expenditures CapEx Growth | -2,727 | -2,305 | -2,723 | -3,114 | -3,288 | -2,576 |
Free Cash Flow Free Cash Flow Growth | 120.29 | 9,507 | 1,929 | 1,869 | -1,522 | -2,257 |
Free Cash Flow Growth | -99.08% | 392.87% | 3.23% | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 41.45% | 40.62% | 39.35% | 37.34% | 35.76% | 34.30% |
Operating Margin | 10.49% | 8.48% | 7.52% | 8.59% | 5.18% | 8.59% |
Pretax Margin | 10.66% | 8.76% | 8.38% | -1.08% | 4.11% | -5.26% |
Profit Margin | 7.53% | 5.85% | 8.21% | -0.10% | 2.59% | -6.87% |
FCF Margin | 0.25% | 21.80% | 4.68% | 4.47% | -4.16% | -6.14% |
Fiscal Year | Current | FY 2026 |
|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Mar '26 Mar 31, 2026 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 0.13% | 0.21% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 31.57 | 27.96 | 22.02 | - | - | - |
Forward PE | 23.97 | 20.30 | 22.14 | - | - | - |
P/FCF Ratio | 959.35 | 7.51 | 38.61 | - | - | - |
PS Ratio | 2.39 | 1.64 | 1.81 | - | - | - |